Compare Cytokinetics Inc (CYTK) vs Schwab US Large Cap Growth ETF (SCHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Schwab US Large Cap Growth ETF — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while Schwab US Large Cap Growth ETF trades at $35.8. The key difference: Schwab US Large Cap Growth ETF is trading nearer its 52-week high, Cytokinetics Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | SCHG | |
|---|---|---|
Market Cap | $10.63B | — |
Sector | Technology | Sector/Thematic |
52-Week High | $87.26 | $35.83 |
52-Week Low | $34.31 | $28.10 |
Enterprise Value | $10.74B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Schwab US Large Cap Growth ETF
SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →
